MicroGen Biotech has raised $3.8 million (€3.47 million) in a funding round led by a number of top US and European agtech investors. MicroGen Biotech is an Irish biotech startup company founded in 2012 by Dr. Xuemei Germaine and a spin-out of the Institute of Technology Carlow. It utilises patented isolation and high-throughput screening methods to isolate functional, high-performance microbiomes for application in agricultural crop production and environmental remediation.
It has a large database of microbes for degrading/immobilising a range of targeted pollutants from soil and for promoting plant growth. Its proprietary microbiome technology blocks the uptake of heavy metals by crops on land that has been contaminated.
MicroGen Biotech focuses on the global market in the Agri-Cleantech sector with specific target market in China. One fifth of Chinese arable land is polluted and stressed, the country has put in place a national safe food and clean soil program to reduce heavy metals. The China Soil Pollution Control Law 2019 encourages the prioritization of bioremediation measures to prevent pollutants from entering food crops.
MicroGen Biotech focuses on three major solutions:
- Environmental Bioremediation: Bioremediation is a treatment process that uses microorganisms (including bacteria) and plants to degrade toxic contaminants into less toxic or non-toxic substances.
- Plant Growth Promotion: A critically important component of the soil/plant microbiome are Plant Growth Promoting Bacteria or PGPB. Application of PGPBs to crop plants have been shown to significantly increase crop yield when used in low input agricultural systems.
- Stressed Agricultural Soil: Stressed soil can be a major inhibitor of agricultural production and globally represents a considerable loss in potential crop yield. Stresses can be biotic (e.g. plant pathogens and insect pests) or abiotic (e.g drought, salinity, heavy metals).